Forglyn Plus 120md Inhaler

Forglyn Plus 120md Inhaler is a triple-combination inhalation therapy formulated for the management of chronic obstructive pulmonary disease (COPD) and severe asthma. This advanced formulation combines three active ingredients — Budesonide (a corticosteroid), Formoterol (a long-acting beta-agonist, LABA), and Glycopyrrolate (a long-acting muscarinic antagonist, LAMA) — to provide comprehensive control over airway obstruction, inflammation, and breathing difficulty.

Budesonide helps reduce airway inflammation and swelling, preventing exacerbations and chronic symptoms. Formoterol works by relaxing the muscles in the airways, allowing better airflow and reducing breathlessness. Glycopyrrolate, on the other hand, helps prevent airway tightening by blocking acetylcholine receptors, keeping airways open for a longer duration.

Together, these agents deliver three-way protection: reducing inflammation, relaxing airway muscles, and preventing bronchoconstriction. This combination is particularly beneficial for patients with moderate-to-severe COPD, emphysema, or chronic bronchitis, where dual therapy may not be sufficient.